February 25, 2016
February 25, 2016 – Vancouver, BC, Canada
The Vancouver Sun recently featured Precision NanoSystems in the health section to highlight the NanoAssemblr Platform as the next generation manufacturing platform for nanomedicines.
Randy Shore of the Vancouver Sun writes, “Using the unique physics of fluids at the nano-scale, the NanoAssemblr combines active ingredients — such as therapeutic strands of DNA or RNA — with complementary particles such as fatty molecules to form a kind of armoured transport. The active ingredients are encapsulated until they reach their target.”
Read the full article and view the interview with Precision NanoSystems’ CEO and co-founder, James Taylor.
Press Release
Jan 29, 2012
Precision NanoSystems, a provider of innovative tools for the development and manufacture of best-in-class nanoparticles for use as medicines, and in medical research, announced that Mr. Andrew Booth, Vice President & General Manager, Instrumen...
News Article
Aug 19, 2017
Nanoparticle encapsulation is gaining momentum as an effective drug delivery system, but traditional manufacturing methods are labor intensive, hard to reproduce, and difficult to scale up. Precision NanoSystems Inc. has developed a proprietary tec...